{"url_path":"/sec/cers/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-03-02","source_url":"https://www.sec.gov/Archives/edgar/data/1020214/0001193125-26-085678-index.html","accession_number":"0001193125-26-085678","cik":"0001020214","ticker":"CERS","issuer_name":"CERUS CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1020214/0001193125-26-085678-index.html","primary_entity_key":"0001020214","primary_entity_name":"CERUS CORP"},"word_count":269,"has_tables":true,"body_markdown":"Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities\n\nOur common stock is traded on the Nasdaq Global Market under the symbol “CERS”. On February 5, 2026, we had 113 holders of record of our common stock.\n\nDividends\n\nWe have not declared or paid dividends on our common stock and do not intend to pay cash dividends on our common stock in the foreseeable future.\n\nStock Performance Graph (1)\n\nThe following graph shows the total stockholder return of an investment of $100 in cash (and the reinvestment of any dividends thereafter) on December 31, 2020, and tracked the performance through December 31, 2025, for (i) our common stock, (ii) the US Benchmark Medical Suppliers TR, and (iii) the Nasdaq Stock Market (United States) Index. Our stock price performance shown in the graph below is based upon historical data and is not indicative of future stock price performance.\n\n \n\nComparison of 5-year Cumulative Total Return on Investment\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDecember 31,\n\n \n\n \n\n2020\n\n \n\n \n\n2021\n\n \n\n \n\n2022\n\n \n\n \n\n2023\n\n \n\n \n\n2024\n\n \n\n \n\n2025\n\n \n\n \n\nCerus Corporation\n\n \n\n$\n\n100.00\n\n \n\n \n\n$\n\n98.41\n\n \n\n \n\n$\n\n52.75\n\n \n\n \n\n$\n\n31.21\n\n \n\n \n\n$\n\n22.25\n\n \n\n \n\n$\n\n29.77\n\n \n\n \n\nNasdaq US Benchmark Medical Supplies TR\n\n \n\n \n\n100.00\n\n \n\n \n\n \n\n121.33\n\n \n\n \n\n \n\n79.56\n\n \n\n \n\n \n\n84.17\n\n \n\n \n\n \n\n76.54\n\n \n\n \n\n \n\n68.69\n\n \n\n \n\nNasdaq\n\n \n\n \n\n100.00\n\n \n\n \n\n \n\n143.64\n\n \n\n \n\n \n\n174.36\n\n \n\n \n\n \n\n167.30\n\n \n\n \n\n \n\n215.22\n\n \n\n \n\n \n\n259.03\n\n \n\n \n\n(1)\nThe graph and the other information furnished in this section is not “soliciting material,” is not deemed “filed” with the SEC and is not to be incorporated by references to any filing of Cerus Corporation under the Securities Act of 1933, as amended or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in such filing."}